7/30/2019 Oncology - Rhabdomyosarcoma v1

1/23

() ,

, .

7/30/2019 Oncology - Rhabdomyosarcoma v1

2/23

,1% .

, , . - 30-60 , 1/3

30 . 2000

3113 , 0,69% 0,69%

. .

6,5%.

7/30/2019 Oncology - Rhabdomyosarcoma v1

3/23

(39 - 54%), (23 - 34%),

(10 - 26%), (4 - 25%).

(AJC)

. ,

.

7/30/2019 Oncology - Rhabdomyosarcoma v1

4/23

2002

(PNET)

.

()

7/30/2019 Oncology - Rhabdomyosarcoma v1

5/23

: , (),

( ), ,

,

, (

). ,

.

7/30/2019 Oncology - Rhabdomyosarcoma v1

6/23

NM 2002 .

()

0 1 5

1*

T1b *

2 5

2*

T2b *

(N)

N

N0 N1

()

0 1

7/30/2019 Oncology - Rhabdomyosarcoma v1

7/23

G

G1

grade

G2

grade

G3

grade G4

grade

7/30/2019 Oncology - Rhabdomyosarcoma v1

8/23

7/30/2019 Oncology - Rhabdomyosarcoma v1

9/23

,.

, .

,

.

7/30/2019 Oncology - Rhabdomyosarcoma v1

10/23

7/30/2019 Oncology - Rhabdomyosarcoma v1

11/23

;

; ,

;

2-3 .

7/30/2019 Oncology - Rhabdomyosarcoma v1

12/23

PNET () (

)

7/30/2019 Oncology - Rhabdomyosarcoma v1

13/23

7/30/2019 Oncology - Rhabdomyosarcoma v1

14/23

7/30/2019 Oncology - Rhabdomyosarcoma v1

15/23

., 14 :

9 I

11 II

13 -

7/30/2019 Oncology - Rhabdomyosarcoma v1

16/23

7/30/2019 Oncology - Rhabdomyosarcoma v1

17/23

7/30/2019 Oncology - Rhabdomyosarcoma v1

18/23

, , .

.

-

3 .

, .

7/30/2019 Oncology - Rhabdomyosarcoma v1

19/23

:

.

.

.

.

7/30/2019 Oncology - Rhabdomyosarcoma v1

20/23

.

,

60 .

44 .

7/30/2019 Oncology - Rhabdomyosarcoma v1

21/23

.

, . VADIC:

V -

-

DIC -

- () - (DTIC)

7/30/2019 Oncology - Rhabdomyosarcoma v1

22/23

I-III

- + +

I-III

- + +

IV

- + +

+

7/30/2019 Oncology - Rhabdomyosarcoma v1

23/23

. 5-

70-80%

50-75%

, .

.